115 related articles for article (PubMed ID: 32357309)
21. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
22. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
23. Relevance of CRISP proteins for epididymal physiology, fertilization, and fertility.
Weigel Muñoz M; Carvajal G; Curci L; Gonzalez SN; Cuasnicu PS
Andrology; 2019 Sep; 7(5):610-617. PubMed ID: 31218833
[TBL] [Abstract][Full Text] [Related]
24. Eukaryotic expression, purification and structure/function analysis of native, recombinant CRISP3 from human and mouse.
Volpert M; Mangum JE; Jamsai D; D'Sylva R; O'Bryan MK; McIntyre P
Sci Rep; 2014 Feb; 4():4217. PubMed ID: 24573035
[TBL] [Abstract][Full Text] [Related]
25. Positive Selection in the Evolution of Mammalian CRISPs.
Vicens A; Treviño CL
J Mol Evol; 2018 Dec; 86(9):635-645. PubMed ID: 30370448
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
27. LINC01342 silencing upregulates microRNA-508-5p to inhibit progression of lung cancer by reducing cysteine-rich secretory protein 3.
Shen Q; Xu Z; Sun G; Wang H; Zhang L
Cell Death Discov; 2021 Sep; 7(1):238. PubMed ID: 34504061
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.
Noh BJ; Sung JY; Kim YW; Chang SG; Park YK
Oncol Lett; 2016 Jun; 11(6):3621-3630. PubMed ID: 27284364
[TBL] [Abstract][Full Text] [Related]
29. Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma.
Udby L; Sørensen OE; Pass J; Johnsen AH; Behrendt N; Borregaard N; Kjeldsen L
Biochemistry; 2004 Oct; 43(40):12877-86. PubMed ID: 15461460
[TBL] [Abstract][Full Text] [Related]
30. Equine CRISP3 modulates interaction between spermatozoa and polymorphonuclear neutrophils.
Doty A; Buhi WC; Benson S; Scoggin KE; Pozor M; Macpherson M; Mutz M; Troedsson MH
Biol Reprod; 2011 Jul; 85(1):157-64. PubMed ID: 21389342
[TBL] [Abstract][Full Text] [Related]
31. Epididymal cysteine-rich secretory proteins are required for epididymal sperm maturation and optimal sperm function.
Hu J; Merriner DJ; O'Connor AE; Houston BJ; Furic L; Hedger MP; O'Bryan MK
Mol Hum Reprod; 2018 Mar; 24(3):111-122. PubMed ID: 29361143
[TBL] [Abstract][Full Text] [Related]
32. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
33. A model of the complex between human beta-microseminoprotein and CRISP-3 based on NMR data.
Ghasriani H; Fernlund P; Udby L; Drakenberg T
Biochem Biophys Res Commun; 2009 Jan; 378(2):235-9. PubMed ID: 19026612
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Thyphronitis G; Moutsopoulos HM
Arthritis Rheum; 2002 Jan; 46(1):215-22. PubMed ID: 11817594
[TBL] [Abstract][Full Text] [Related]
35. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
36. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
37. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
38. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
39. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
40. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
